logo
CNBC Daily Open: Rely on the official U.S. jobs report, but consider what ADP is saying

CNBC Daily Open: Rely on the official U.S. jobs report, but consider what ADP is saying

CNBC7 hours ago
There's a scene in the cinematic masterpiece Mean Girls in which a character writes in big bloody script: "DO NOT TRUST HER."
Apologies in advance to the good folks at ADP, who I'm sure are doing good work processing private payrolls. But we might want to keep in mind the above warning when assessing the monthly ADP jobs report.
Official labor numbers from the U.S. Bureau of Labor Statistics showed a higher-than-expected increase of147,000 jobs in June. The ADP report, released Wednesday, pointed to a decrease of 33,000 private sector jobs.
That's not just a difference in magnitude, but also of direction. Emphasizing this point, the unemployment rate in June fell to 4.1% from 4.2% in the month before, defying a forecast for an increase to 4.3%.
The details lurking below the official jobs report, however, suggest I could be a tad unfair to the ADP report.
Jobs in the government rose by 73,000 in June, making up around half of the total nonfarm payroll growth for the month, as noted by CNBC's Alex Harring. The ADP report only measures private payrolls — which exclude government jobs.
"The headline job gains and surprising dip in unemployment are undoubtedly good news, but for job seekers outside of healthcare & social assistance, local government, and public education, the gains will likely ring hollow," wrote Cory Stahle, economist at Indeed Hiring Lab.
The huge divergence between the ADP and BLS reports, then, might not be that much of a statistical aberration — and could point to a growing schism in the U.S. labor market.
The U.S. economy added more jobs in June than expected. Nonfarm payrolls increased a seasonally adjusted 147,000 for the month, higher than the estimate for 110,000. The unemployment rate also ticked down to 4.1% from 4.2% in May.
The S&P 500 and Nasdaq Composite notch new records. Both indexes rose Thursday to extend their streak of new closing highs. Yield on the 10-year U.S. Treasury jumped. The Stoxx Europe 600 added 0.47%, pushing itself out of a loss.
Apple's iPhone sales in China grow. The figure jumped 8% year on year in the second quarter of 2025. That's the first time in two years Apple has recorded an increase in sales in China, according to Counterpoint Research.
Trump's massive bill passed by U.S. government. On Thursday, the House of Representatives voted in favor of the tax-and-spending bill, with a finally vote tally of 218-214. The passage of the bill is a major political victory for U.S. President Donald Trump.
[PRO] A relief to European renewable energy firms. Amendments in Trump's bill gave renewable stocks a boost and could mean the "worst-case scenario" for the sector might not come to pass, an analyst said.
What the U.S.-Vietnam trade deal tells us about the future of tariffs
Under the agreement between Vietnam and the U.S., Washington will apply a 20% duty on Vietnamese imports — sharply below the 46% rate Trump had imposed in early April. U.S. imports to Vietnam will not be subject to tariffs.
"What we learned from the Vietnam deal is, if anything, the tariffs are going to go up from here, not down," Sebastian Raedler, head of European equity strategy at BofA, told CNBC's "Europe Early Edition" on Thursday.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Piper Sandler Reaffirms Buy on Amgen Amid MariTide Tolerability Update
Piper Sandler Reaffirms Buy on Amgen Amid MariTide Tolerability Update

Yahoo

time22 minutes ago

  • Yahoo

Piper Sandler Reaffirms Buy on Amgen Amid MariTide Tolerability Update

Amgen Inc. (NASDAQ:AMGN) ranks among the best set-it-and-forget-it stocks to buy. On June 24, Piper Sandler reaffirmed its Overweight rating and $328 price target for Amgen Inc. (NASDAQ:AMGN) in response to the company's disclosure of comprehensive MariTide tolerability data. 360b / The obesity medication's gastrointestinal tolerability profile unnerved the market, particularly the frequency of nausea and vomiting, which at first seemed more problematic than alternatives. Piper Sandler's study however, shows that both one- and two-step dose escalation regimens showed a noticeable improvement in the drug's tolerability profile, consistent with management's claims at the December top-line results announcement. According to the firm, the weight loss drug could produce a more commercially acceptable nausea and vomiting profile due to the much lower starting dosages and three-step dose escalation protocols included in the pivotal studies. Amgen Inc. (NASDAQ:AMGN) is a global biopharmaceutical company that focuses on human treatments for cardiovascular, hematology, inflammation, cancer, and bone health. While we acknowledge the potential of AMGN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤

European shares edge lower as US tariff deadline looms
European shares edge lower as US tariff deadline looms

Yahoo

time24 minutes ago

  • Yahoo

European shares edge lower as US tariff deadline looms

(Reuters) -European shares edged lower on Friday, as investors weighed uncertainty over U.S. trade deals, with the July 9 deadline fast approaching. The pan-European STOXX 600 index fell 0.4% to 541.61 points, as of 0704 GMT, and was on track to log a weekly decline. Other major regional indexes also traded lower. Trump said on Thursday that Washington will start sending letters to countries on Friday specifying what tariff rates they will face on imports to the United States. With Trump's 90-day pause on higher U.S. tariffs ending next week, investors have taken a cautious stance as several large trading partners, including the European Union, are yet to clinch trade deals. The EU is pushing for an "agreement in principle" with the U.S. before the deadline. Mining-related stocks led sectoral declines with a 1.1% fall, while technology stocks lost 0.8%. Meanwhile, Trump's tax-cut legislation cleared its final hurdle in the U.S. Congress on Thursday. Trump will sign it into law later in the day. French train maker Alstom rose 1.1% on a 2 billion euro ($2.4 billion) contract from the New York Metropolitan Transportation Authority.

Gold Gains as Trump Says US Will Impose Tariffs Next Month
Gold Gains as Trump Says US Will Impose Tariffs Next Month

Yahoo

time25 minutes ago

  • Yahoo

Gold Gains as Trump Says US Will Impose Tariffs Next Month

(Bloomberg) -- Gold rose — putting it on track for a 2% weekly gain — as President Donald Trump said some US trading partners would face tariffs from August 1. Foreign Buyers Swoop on Cape Town Homes, Pricing Out Locals NYC Commutes Resume After Midtown Bus Terminal Crash Chaos Struggling Downtowns Are Looking to Lure New Crowds Massachusetts to Follow NYC in Making Landlords Pay Broker Fees What Gothenburg Got Out of Congestion Pricing Bullion rose 0.5% to around $3,340 an ounce on Friday as investors weighed the latest trade comments from the president, who said the administration will start sending letters on Friday that set new levy rates for several nations. 'They'll be fully covered and they'll range in value from maybe 60 or 70% tariffs to 10 and 20% tariffs,' he said late Thursday. Trump told reporters that about '10 or 12' letters would go out Friday, with additional letters coming 'over the next few days.' Trump has long threatened that if countries fail to reach deals with a July 9 deadline, he would impose higher rates on them, raising the stakes for trading partners. So far, the administration has announced deals with the UK and Vietnam and agreed to a truce with China that saw the world's two largest economies ease tit-for-tat tariffs. There's concern a growing trade war could dent the global economy, which would be a boon for haven assets like gold. Elsewhere, investors continued to assess the path forward for the Federal Reserve's interest-rate cutting cycle, after a Thursday report showed US payroll figures surprised on the upside, while the unemployment rate came in lower than expectations. That prompted traders to exit already slim bets on a rate reduction at the Fed's July meeting. Higher rates typically weigh on gold, which doesn't bear interest. Gold is up by more than a quarter this year, trading about $160 short of a record set in April. The precious metal has been bolstered by demand for havens as investors grapple with heightened geopolitical and trade tensions, as well as ongoing strong demand from global central banks. Spot gold was up 0.5% to $3,341.48 an ounce as of 1:23 p.m. in Singapore. The Bloomberg Dollar Spot Index slipped 0.2%, putting it on track for a weekly loss of 0.5%. Silver was steady, while palladium and platinum climbed. Elsewhere, investors were weighing the potential economic impact of Trump's multitrillion fiscal package, after the House passed the bill on Thursday. The sweeping legislation is expected to widen the US deficit by $3.4 trillion over the next decade, according to the nonpartisan Congressional Budget Office. That could bolster demand for havens such as gold. SNAP Cuts in Big Tax Bill Will Hit a Lot of Trump Voters Too America's Top Consumer-Sentiment Economist Is Worried How to Steal a House China's Homegrown Jewelry Superstar Sperm Freezing Is a New Hot Market for Startups ©2025 Bloomberg L.P.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store